Use of renin–angiotensin–aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study

  1. de Abajo, F.J.
  2. Rodríguez-Martín, S.
  3. Lerma, V.
  4. Mejía-Abril, G.
  5. Aguilar, M.
  6. García-Luque, A.
  7. Laredo, L.
  8. Laosa, O.
  9. Centeno-Soto, G.A.
  10. Ángeles Gálvez, M.
  11. Puerro, M.
  12. González-Rojano, E.
  13. Pedraza, L.
  14. de Pablo, I.
  15. Abad-Santos, F.
  16. Rodríguez-Mañas, L.
  17. Gil, M.
  18. Tobías, A.
  19. Rodríguez-Miguel, A.
  20. Rodríguez-Puyol, D.
  21. Barreira-Hernandez, D.
  22. Zubiaur, P.
  23. Santos-Molina, E.
  24. Pintos-Sánchez, E.
  25. Navares-Gómez, M.
  26. Aparicio, R.M.
  27. García-Rosado, V.
  28. Gutiérrez-Ortega, C.
  29. Pérez, C.
  30. Ascaso, A.
  31. Elvira, C.
  32. MED-ACE2-COVID19 study group
  33. Show all authors +
Journal:
The Lancet

ISSN: 1474-547X,  0140-6736

Year of publication: 2020

Volume: 395

Issue: 10238

Pages: 1705-1714

Type: Article

DOI: 10.1016/S0140-6736(20)31030-8 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

Data source: Scopus